Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-02-24 @ 10:56 AM
Study NCT ID:
NCT02337751
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2015-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-10
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-14
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-09
First Submit QC Date:
None
Study First Post Date:
2015-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-25
Results First Submit QC Date:
None
Results First Post Date:
2019-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-17
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL